Association of the OSCAR promoter polymorphism with BMD in postmenopausal women

Journal of Bone and Mineral Research

Volumn 20, Issue 8, 2005, Pages 1342-1348

  Kim, Ghi Su ^a   Koh, Jung Min ^a   Chang, Jae Suk ^a   Park, Byung Lae ^b   Kim, Lyoung Hyo ^b   Park, Eui Kyun ^c   Kim, Shin Yoon ^c   Shin, Hyoung Doo ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

Author keywords

BMD; Osteoclast associated receptor gene; Polymorphism; Postmenopausal women

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; AGED; ALLELE; ANALYTIC METHOD; ARTICLE; BONE DENSITY; BONE MINERAL; BONE RADIOGRAPHY; BONE STRENGTH; DNA FLANKING REGION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OSCAR GENE; OSTEOCLAST; POSTMENOPAUSE; PROMOTER REGION; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; FEMUR; GENETIC MARKERS; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RECEPTORS, CELL SURFACE; THORACIC VERTEBRAE;

EID: 22744444441     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.050320     Document Type: Article

References (29)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy 2001 Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795.
2. Arden NK, Spector TD 1997 Genetic influences on muscle strength, lean body mass, and bone mineral density: A twin study. J Bone Miner Res 12:2076-2081.
3. Eisman JA 1999 Genetics of Osteoporosis. Endocr Rev 20:788-804.
4. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N 1994 The diagnosis of Osteoporosis. J Bone Miner Res 9:1137-1141.
5. Biswas RN, Baker DN, Hruska KN, Chellaiah MN 2004 Polyphosphoinositides- dependent regulation of the osteoclast actin cytoskeleton and bone resorption. BMC Cell Biol 5:19.
6. Karst M, Gorny G, Galvin RJ, Oursler MJ 2004 Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol 200:99-106.
7. Baron R 2004 Arming the osteoclast. Nat Med 10:458-460.
8. Teitelbaum SL 2000 Bone resorption by osteoclasts. Science 289:1504-1508.
9. Teitelbaum SL, Ross FP 2003 Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649.
10. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342.
11. Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT 2002 Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol 23:81-88.
12. Kim N, Takami M, Rho J, Josien R, Choi Y 2002 A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med 195:201-209.
13. So H, Rho J, Jeong D, Park R, Fisher DE, Ostrowski MC, Choi Y, Kim N 2003 Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem 278:24209-24216.
14. Merck E, Gaillard C, German DM, Montero-Julian F, Durand I, Zurawski SM, Menetrier-Caux C, Carra G, Lebecque S, Trinchieri G, Bates EE 2004 OSCAR is an FcR{gamma}-associated receptor expressed by myeloid cells, involved in antigen presentation and activation of human dendritic cells. Blood 104:1386-1395.
15. Nathan H 1962 Osteophytes of the vertebral column: An anatomical study of their development according to age, race, and sex with considerations as to their etiology and significance. J Bone Joint Surg Am 44:243-268.
16. Livak KJ 1999 Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149.
17. Hedrick PW 1987 Gametic disequilibrium measures: Proceed with caution. Genetics 117:331-341.
18. Hedrick P, Kumar S 2001 Mutation and linkage disequilibrium in human mtDNA. Eur J Hum Genet 9:969-972.
19. Stephens M, Smith NJ, Donnelly P 2001 A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
20. Nyholt DR 2004 A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769.
21. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL, Kolchanov NA 1998 Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26:362-367.
22. Faulkner KG, Gluer CC, Estilo M, Genant HK 1993 Cross-calibration of DXA equipment: Upgrading from a Hologic QDR 1000/W to a QDR 2000. Calcif Tissue Int 52:79-84.
23. Nelson DA, Barondess DA, Hendrix SL, Beck TJ 2000 Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women. J Bone Miner Res 15:1992-1997.
24. Merck E, de Saint-Vis B, Scuiller M, Gaillard C, Caux C, Trinchieri G, Bates EE 2005 Fc receptor (gamma)-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responses. Blood 105:3623-3632.
25. Arron JR, Choi Y 2000 Bone versus immune system. Nature 408:535-536.
26. Lorenzo J 2000 Interactions between immune and bone cells: New insights with many remaining questions. J Clin Invest 106:749-752.
27. Muller B 2002 Cytokine imbalance in non-immunological chronic disease. Cytokine 18:334-339.
28. Walsh MC, Choi Y 2003 Biology of the TRANCE axis. Cytokine Growth Factor Rev 14:251-263.
29. Herdegen T, Leah JD 1998 Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28:370-490.